During cancer progression, upregulation of multiple pro-angiogenic factors, such as vascular endothelial growth factor A (VEGFA), PDGF, and IGF-1, and downregulation of anti-angiogenic factors, such as ENS and PF-4, contributes to pathological angiogenesis (9, 10). The gene discussed is VEGFA; the disease is cancer.